Kovack Advisors’s Boston Scientific BSX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
Sell
-5,750
Closed -$360K 1080
2026
Q1
$360K Sell
5,750
-11,063
-66% -$885K 0.02% 692
2025
Q4
$1.6M Buy
16,813
+13,863
+470% +$1.36M 0.07% 248
2025
Q3
$288K Sell
2,950
-212
-7% -$22K 0.03% 475
2025
Q2
$340K Sell
3,162
-657
-17% -$66.5K 0.03% 430
2025
Q1
$385K Buy
3,819
+80
+2% +$8.06K 0.04% 365
2024
Q4
$334K Buy
+3,739
New +$329K 0.03% 418
2022
Q2
Sell
-6,900
Closed -$305K 626
2022
Q1
$305K Buy
+6,900
New +$299K 0.03% 525
2020
Q1
Sell
-9,181
Closed -$415K 475
2019
Q4
$415K Buy
9,181
+1,875
+26% +$78.5K 0.07% 284
2019
Q3
$297K Buy
+7,306
New +$310K 0.06% 336
2019
Q1
Sell
-6,238
Closed -$220K 465
2018
Q4
$220K Buy
+6,238
New +$226K 0.06% 325
2016
Q3
Sell
-10,837
Closed -$253K 273
2016
Q2
$253K Buy
+10,837
New +$234K 0.13% 183

Other funds holding BSX

Kovack Advisors's BSX Position: Q2 2026 in Review

Kovack Advisors sold out of Boston Scientific (BSX) in Q2 2026, closing a stake of 5,750 shares — an estimated $360K sold.

Kovack Advisors first reported a position in BSX in Q2 2016 and held it in 11 quarters. The position peaked at $1.6M in Q4 2025. 1,478 funds tracked by Wall St. Rank hold BSX as of Q2 2026.

  • Kovack Advisors reported no remaining Boston Scientific position as of Q2 2026 after selling out during the quarter.
  • Kovack Advisors sold 5,750 Boston Scientific shares in Q2 2026, an estimated $360K.
  • Kovack Advisors first reported a position in Boston Scientific in Q2 2016 and held it in 11 quarters.
  • Kovack Advisors's Boston Scientific position peaked at $1.6M in Q4 2025.
  • 1,478 funds tracked by Wall St. Rank held Boston Scientific as of Q2 2026.

Based on Kovack Advisors's 13F filing for Q2 2026, filed 29 Jul 2026.